Zacks Research Issues Positive Outlook for THC Earnings

Tenet Healthcare Corporation (NYSE:THC) – Equities researchers at Zacks Research raised their Q1 2026 earnings per share estimates for Tenet Healthcare in a note issued to investors on Wednesday, February 25th. Zacks Research analyst Team now anticipates that the company will earn $4.14 per share for the quarter, up from their previous forecast of $3.73. The consensus estimate for Tenet Healthcare’s current full-year earnings is $12.24 per share. Zacks Research also issued estimates for Tenet Healthcare’s Q2 2026 earnings at $4.10 EPS, FY2026 earnings at $16.76 EPS, Q3 2027 earnings at $4.01 EPS, Q4 2027 earnings at $3.28 EPS and FY2027 earnings at $16.35 EPS.

A number of other analysts have also issued reports on the company. Morgan Stanley reissued an “overweight” rating and issued a $260.00 price target on shares of Tenet Healthcare in a research note on Thursday, February 12th. Jefferies Financial Group raised their target price on shares of Tenet Healthcare from $250.00 to $265.00 and gave the stock a “buy” rating in a research report on Thursday, February 12th. TD Cowen reaffirmed a “buy” rating on shares of Tenet Healthcare in a research report on Thursday, February 12th. Wells Fargo & Company reissued an “overweight” rating and set a $265.00 price objective on shares of Tenet Healthcare in a research note on Monday, February 16th. Finally, Guggenheim upped their price objective on Tenet Healthcare from $257.00 to $271.00 and gave the stock a “buy” rating in a report on Friday, February 13th. One investment analyst has rated the stock with a Strong Buy rating, eighteen have issued a Buy rating and three have issued a Hold rating to the company. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus price target of $247.67.

Tenet Healthcare Trading Down 0.4%

Shares of THC opened at $238.68 on Monday. Tenet Healthcare has a fifty-two week low of $109.82 and a fifty-two week high of $240.83. The stock has a fifty day moving average of $206.02 and a two-hundred day moving average of $200.15. The company has a debt-to-equity ratio of 2.18, a quick ratio of 1.68 and a current ratio of 1.76. The company has a market capitalization of $20.76 billion, a PE ratio of 15.41, a price-to-earnings-growth ratio of 1.18 and a beta of 1.39.

Tenet Healthcare (NYSE:THC) last issued its quarterly earnings results on Wednesday, February 11th. The company reported $4.70 EPS for the quarter, topping analysts’ consensus estimates of $4.08 by $0.62. The business had revenue of $5.53 billion during the quarter, compared to the consensus estimate of $5.47 billion. Tenet Healthcare had a net margin of 6.60% and a return on equity of 26.33%. The company’s quarterly revenue was up 8.9% compared to the same quarter last year. During the same period in the previous year, the firm posted $3.44 earnings per share. Tenet Healthcare has set its FY 2026 guidance at 16.190-18.470 EPS.

Hedge Funds Weigh In On Tenet Healthcare

A number of institutional investors and hedge funds have recently added to or reduced their stakes in THC. WCM Investment Management LLC grew its stake in Tenet Healthcare by 244.4% in the third quarter. WCM Investment Management LLC now owns 510,224 shares of the company’s stock worth $102,657,000 after purchasing an additional 362,083 shares in the last quarter. AlphaQuest LLC raised its holdings in shares of Tenet Healthcare by 238.3% during the third quarter. AlphaQuest LLC now owns 5,965 shares of the company’s stock worth $1,211,000 after purchasing an additional 4,202 shares during the period. Winnow Wealth LLC acquired a new position in shares of Tenet Healthcare in the 3rd quarter valued at about $1,129,000. Cerity Partners LLC raised its stake in Tenet Healthcare by 10.4% during the second quarter. Cerity Partners LLC now owns 120,623 shares of the company’s stock worth $21,230,000 after acquiring an additional 11,395 shares during the period. Finally, Savant Capital LLC grew its holdings in shares of Tenet Healthcare by 27.5% during the third quarter. Savant Capital LLC now owns 16,894 shares of the company’s stock valued at $3,430,000 after purchasing an additional 3,647 shares during the last quarter. 95.44% of the stock is owned by hedge funds and other institutional investors.

Insider Activity

In other news, Director Nadja West sold 2,178 shares of the company’s stock in a transaction on Monday, December 15th. The shares were sold at an average price of $197.47, for a total value of $430,089.66. Following the completion of the transaction, the director directly owned 28,480 shares in the company, valued at approximately $5,623,945.60. This represents a 7.10% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. 0.81% of the stock is owned by corporate insiders.

Tenet Healthcare News Summary

Here are the key news stories impacting Tenet Healthcare this week:

• Positive Sentiment: Wall Street Zen upgraded THC to a “Strong‑Buy,” signaling fresh buy-side interest and likely supporting demand for the stock. Article Title
• Positive Sentiment: Zacks and other outlets have raised near‑term earnings estimates (Q1/Q2 FY2026 and FY2026), which supports the company’s earnings trajectory and provides backing for current valuation assumptions. Article Title
• Neutral Sentiment: A Yahoo Finance piece questions whether it’s too late to buy after an ~89% one‑year rally — this is market commentary on valuation and investor sentiment rather than new company fundamentals, and can amplify volatility as investors reassess upside. Article Title
• Negative Sentiment: Zacks’ detailed notes are mixed: while they raised FY2026 and some near‑term quarter forecasts, they trimmed several FY2027 and late‑year quarterly estimates (Q3/Q4 2027 and FY2027), indicating analyst caution about longer‑term growth and limiting upward re‑rating potential. Article Title

Tenet Healthcare Company Profile

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.